| Alzheimer's disease |
289 |
| Multiple sclerosis - a review |
106 |
| Huntington's disease: a clinical review |
85 |
| European Academy of Neurology guideline on trigeminal neuralgia |
40 |
| Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4 |
28 |
| ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis |
26 |
| Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study |
25 |
| European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-18-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus |
23 |
| Syndrome and outcome of antibody-negative limbic encephalitis |
21 |
| Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China |
20 |
| European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre-hospital management of stroke |
19 |
| Serum neurofilament light chain in patients with acute cerebrovascular events |
19 |
| Associated conditions in small fiber neuropathy - a large cohort study and review of the literature |
18 |
| Stroke-related epilepsy |
17 |
| Non-invasive brain stimulation for fine motor improvement after stroke: a meta-analysis |
16 |
| Thrombectomy in posterior circulation stroke: differences in procedures and outcome compared to anterior circulation stroke in the prospective multicentre REVASK registry |
16 |
| OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study |
15 |
| Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome |
15 |
| Non-motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life |
14 |
| The idiopathic normal-pressure hydrocephalus Radscale: a radiological scale for structured evaluation |
14 |
| Ischaemic stroke |
14 |
| Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants |
14 |
| Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease |
13 |
| Atypical parkinsonian syndromes: a general neurologist's perspective |
13 |
| Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis |
13 |
| Early versus later treatment start in multiple sclerosis: a register-based cohort study |
13 |
| Impact of intravenous thrombolysis and emergent carotid stenting on reperfusion and clinical outcomes in patients with acute stroke with tandem lesion treated with thrombectomy: a collaborative pooled analysis |
13 |
| Thrombectomy outcomes for acute stroke patients with anterior circulation tandem lesions: a clinical registry and an update of a systematic review with meta-analysis |
12 |
| Pain in Parkinson's disease: facts and uncertainties |
12 |
| Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study |
12 |
| Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis |
12 |
| TTTCA repeat expansion causes familial cortical myoclonic tremor with epilepsy |
12 |
| Management of psychogenic non-epileptic seizures: a multidisciplinary approach |
12 |
| Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension |
12 |
| Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis |
12 |
| Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy |
11 |
| Dystonia: diagnosis and management |
11 |
| The spectrum of progressive multifocal leukoencephalopathy: a practical approach |
11 |
| Is there a benefit of mechanical thrombectomy in patients with large stroke (DWI-ASPECTS 5)? |
11 |
| Clinical activity after fingolimod cessation: disease reactivation or rebound? |
11 |
| Hemostasis biomarkers in multiple sclerosis |
11 |
| Ictal and interictal electric source imaging in pre-surgical evaluation: a prospective study |
10 |
| Developmental and neurodegenerative damage in Friedreich's ataxia |
10 |
| Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK |
10 |
| Effects of exercise training on multiple sclerosis biomarkers of central nervous system and disease status: a systematic review of intervention studies |
10 |
| Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain |
10 |
| Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease |
10 |
| Protection against stroke with glucagon-like peptide 1 receptor agonists: a systematic review and meta-analysis |
10 |
| Is essential tremor a single entity? |
10 |
| Diagnostic criteria for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation |
10 |
